Drug pricing regulator fixes prices of 40 formulation drugs

The regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combination drugs. The revised prices will have an impact on the manufacturers of these formulations, including Sun Pharma and Zydus Healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gNjwMO
via IFTTT